Recently, circulating microRNAs (miRNA) have been investigated as novel biomarkers in heart failure, with specific miRNA signatures showing an even better sensitivity for left ventricular dysfunction compared to traditional peptide markers such as NT-proBNP or BNP9. Here, NPPB is linked to heart failure.